Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before symptoms emerge.

Heart failure (HF) is a chronic and progressive cardiovascular condition associated with significant morbidity, mortality and ...

The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the ...

On World Cancer Day 2026, know how precision onco-haematology is transforming blood cancer care with targeted therapies, ...

Key opportunities in the Global Esoteric Testing Market include addressing rising chronic disease rates, demand for molecular diagnostics in personalized medicine, and expanding use of liquid biopsy ...

What started as a bold idea — to make high-quality woodworking education accessible, modern, and industry-driven — has evolved into a proven model that is gaining momentum across the country. The ...

The Rwanda Forensic Institute (RFI) is in the final stages of preparations to introduce prenatal DNA testing for unborn ...

NeoGenomics is transitioning from a commodity diagnostic provider to a comprehensive precision oncology platform. Read why ...

With the NFL regular season in the books, the Next Gen Stats analytics team dives into advanced data to spotlight the best of the best at each position. Check out the NGS 2025 NFL All-Pro Team, with ...

Intel's Panther Lake chip uses new 18A manufacturing process Intel aims to regain market share from AMD with new chip AMD and Nvidia also present at CES with AI chip announcements Jim Johnson, senior ...

Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...

With the MiSeq™ i100 Series, Illumina continues to set the highest standards. Advancements in system design, sequencing chemistry, and data analysis deliver the simplest, fastest benchtop sequencing ...